SCHEMBL7874870

SCHEMBL7874870

CCCCOC(=O)N1CC[C@@H](CCCc2ccccc2)[C@@H](O)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.46
HTR2A P28223 1/20 0.46
HTR7 P34969 1/20 0.46
OPRM1 P35372 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
GRIN2B Q13224 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CCR8 P51685 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM5 P08912 1/20 0.41
CHRM1 P11229 1/20 0.41
CHRM3 P20309 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7874873 1.00 ADORA3 (0.46) ADORA3HTR2AHTR7OPRM1SIGMAR1
SCHEMBL7874875 1.00 ADORA3 (0.46) ADORA3HTR2AHTR7OPRM1SIGMAR1
SCHEMBL7872003 0.84 ADORA3 (0.41) ADORA3HTR2AHTR7OPRM1SIGMAR1
SCHEMBL7872004 0.84 ADORA3 (0.41) ADORA3HTR2AHTR7OPRM1SIGMAR1
SCHEMBL3932037 0.84 PPARG (0.45) ADORA3HTR2AHTR7OPRM1SIGMAR1
SCHEMBL16897790 0.77 LMNA (0.48) ADORA3HTR2AHTR7OPRM1SIGMAR1
SCHEMBL30716259 0.76 SMN1; SMN2 (0.48) L3MBTL1SMN1; SMN2NPC1RAB9ACHRM1
SCHEMBL29584843 0.76 KMT2A (0.46) ADORA3HTR2AHTR7OPRM1SIGMAR1
SCHEMBL6983413 0.76 L3MBTL1 (0.62) L3MBTL1MEN1KMT2AHRH3SMN1; SMN2
SCHEMBL13575597 0.76 SMN1; SMN2 (0.60) MEN1KMT2AGRIN2BSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US disclosed